Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Mar 30 2017

Von Willebrand Disease

.Snapshot
  •  A 30-year-old woman presents with a recurrent history of nosebleeds and heavy menses. She recently read that taking a baby aspirin was good for the heart. However, ever since she started taking aspirin, she has been experiencing more and more nosebleeds. Her father and paternal uncle similarly have histories of prolonged nosebleeds. Labs show increased PTT, normal PT, and increased bleeding time.
Introduction

  • Inherited mixed platelet and coagulation disorder from deficiency in von Willebrand factor (vWF)
  • Genetics
    • autosomal dominant
  • Epidemiology
    • most common inherited bleeding disorder
    • female to male ratio 2:1
      • likely due to more women being diagnosed due to menorrhagia
    • more likely in Caucasians
  • Pathogenesis
    • affects coagulation - vWF carries and protects factor VIII
      • produced by endothelial cells and megakaryocytes
      • intrinsic pathway coagulation defect
    • affects platelets – vWF is important in platelet adherence to endothelial lining
      • platelet aggregation is normal (mediated by fibrinogen)
Presentation
  • Symptoms
    • mucocutaneous bleeding
      • epistaxis
      • gingival bleeding
      • petechiae
      • easy bruising
      • menorrhagia
    • can be asymptomatic
    • increased bleeding after aspirin use
Evaluation
  • Normal or ↑ PTT (like hemophilia)
  • Normal PT
  • ↑ bleeding time (unlike hemophilia)
  • CBC
    • normal platelet count and appearance
    • may have anemia
  • ↓ von Willebrand factor antigen
  • Diagnosis by ristocetin cofactor assay
    • tests ability of platelets to bind to ristocetin (artificial endothelial surface)
    • ↓ platelet agglutination
  • Repeat testing may be required as vWF is an acute phase reactant
    • stress, surgery, pregnancy and oral contraceptives may increase vWF levels
Differential Diagnosis
  • Bernard-Soulier syndrome
  • Glanzmann thrombasthenia
  • Hemophilia
Treatment
  • DDAVP (desmopressin acetate)
    • releases vWF stored in endothelial cells
  • Factor VIII replacement if refractory to DDAVP
    • contains vWF
  • Cryoprecipitate no longer used
Prognosis, Prevention, and Complications
  • Prognosis
    • most are mild or moderate in severity
    • variable prognosis
  • Prevention
    • avoid aspirin
  • Complications
    • excessive bleeding, especially during childbirth
Question
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options